Scores are 0 to 100 against every US stock we track; 50 is average. Recomputed after every US market close.
Fiscal year to January 2026, from the company's annual filing with the SEC.
| Salesyearly sales | $4.7B |
| Sales growthchange from the year before | +29.2% |
| Gross marginshare of sales left after the direct cost of what it sells | 67.2% |
| Operating marginshare of sales left after running the business | -30.6% |
| Net marginshare of sales kept as profit | -28.4% |
| Free-cash-flow marginspare cash generated per $100 of sales | 23.9% |
| Return on invested capitalprofit made on each $100 put into the business | -58.9% |
| Return on equityprofit vs. shareholders' accounting value | -69.1% |
| Change in share countnegative = the company is buying back its shares | +1.4% |
3 insiders sold $108.3M (all under pre-arranged plans) on the open market.
| Kleinerman ChristianEVP, Product Management | Sold (plan)Aug 3 | 10,000 shat $297.00 · $3.0M |
| Kleinerman ChristianEVP, Product Management | Sold (plan)Jul 31 | 29,986 shat $300.00 · $9.0M |
| Dageville BenoitDirector | Sold (plan)Jul 29 | 50,000 shat $280.00 · $14.0M |
From Form 4 filings with the SEC. Open-market trades only. "Plan" = a sale set up in advance under a 10b5-1 plan, usually routine.
Not financial advice. Research and education only: the same view for everyone, with no regard to your circumstances. Past results do not predict future ones. Decide for yourself or with a licensed adviser. Terms · Privacy